Cargando…

Pharmacologic prevention of migraine

Detalles Bibliográficos
Autores principales:	Tzankova, Velina, Becker, Werner J., Chan, Tommy L.H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	CMA Impact Inc. 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904820/ https://www.ncbi.nlm.nih.gov/pubmed/36746481 http://dx.doi.org/10.1503/cmaj.221607

Ejemplares similares

Prévention pharmacologique de la migraine
por: Tzankova, Velina, et al.
Publicado: (2023)

Diagnosis and acute management of migraine
por: Tzankova, Velina, et al.
Publicado: (2023)

Diagnostic et traitement à action immédiate de la migraine
por: Tzankova, Velina, et al.
Publicado: (2023)

Non-Pharmacological Approaches for Migraine
por: Puledda, Francesca, et al.
Publicado: (2018)

Preventive non–pharmacological treatment and nitric oxide in chronic migraine
por: Ciancarelli, I., et al.
Publicado: (2005)

Recent advances in the pharmacological management of migraine
por: Pascual, Julio
Publicado: (2009)

Migraine Treatment: Towards New Pharmacological Targets
por: Silvestro, Marcello, et al.
Publicado: (2023)

Emerging Pharmacological Treatments for Migraine in the Pediatric Population
por: Iannone, Luigi Francesco, et al.
Publicado: (2022)

Migraine Pharmacological Treatment and Cognitive Impairment: Risks and Benefits
por: Russo, Mirella, et al.
Publicado: (2022)

Pharmacological analysis of red-wine-induced migrainous headaches
por: Peatfield, Richard C., et al.
Publicado: (2003)

Migraine and Current Pharmacologic Management
por: Okobi, Okelue E, et al.
Publicado: (2022)

Pharmacological interventions for prophylaxis of vestibular migraine
por: Webster, Katie E, et al.
Publicado: (2023)

Use of Pharmacological and Non-Pharmacological Strategies by Community-Dwelling Adults to Manage Migraine: A Systematic Review
por: Marupuru, Srujitha, et al.
Publicado: (2023)

Pharmacological treatment of attacks in juvenile migraine
por: Gallai, Beatrice, et al.
Publicado: (2004)

New players in the preventive treatment of migraine
por: Mitsikostas, Dimos D., et al.
Publicado: (2015)

Atogepant for the prevention of episodic migraine in adults
por: Switzer, Maranda Paige, et al.
Publicado: (2022)

Migraine pathogenesis and state of pharmacological treatment options
por: Sprenger, Till, et al.
Publicado: (2009)

Frovatriptan: A Review of Pharmacology, Pharmacokinetics and Clinical Potential in the Treatment of Menstrual Migraine
por: Balbisi, Ebrahim A
Publicado: (2006)

A systematic review of economic evaluations of pharmacological treatments for adults with chronic migraine
por: Khanal, Saval, et al.
Publicado: (2022)

Non‐pharmacological interventions for prophylaxis of vestibular migraine
por: Webster, Katie E, et al.
Publicado: (2023)

Pharmacological interventions for acute attacks of vestibular migraine
por: Webster, Katie E, et al.
Publicado: (2023)

Migraine management: Non-pharmacological points for patients and health care professionals
por: Haghdoost, Faraidoon, et al.
Publicado: (2022)

The acute and preventative treatment of episodic migraine
por: Miller, Sarah
Publicado: (2012)

Preventive Agents for Migraine: Focus on the Antiepileptic Drugs
por: Shahien, R., et al.
Publicado: (2012)

Preventive treatment in migraine and the new US guidelines
por: Estemalik, E, et al.
Publicado: (2013)

New Generation Gepants: Migraine Acute and Preventive Medications
por: Moreno-Ajona, David, et al.
Publicado: (2022)

Petasites for Migraine Prevention: New Data on Mode of Action, Pharmacology and Safety. A Narrative Review
por: Borlak, Jürgen, et al.
Publicado: (2022)

Potential Protective Mechanisms of Ketone Bodies in Migraine Prevention
por: Gross, Elena C., et al.
Publicado: (2019)

Hypervigilance, Allostatic Load, and Migraine Prevention: Antibodies to CGRP or Receptor
por: Blumenfeld, Andrew, et al.
Publicado: (2021)

Topiramate: Safety and Efficacy of its Use in the Prevention and Treatment of Migraine
por: Minton, Ginger C., et al.
Publicado: (2011)

Topiramate in the prevention of pediatric migraine: literature review
por: Ferraro, Diana, et al.
Publicado: (2008)

Acute and Preventive Management of Migraine during Menstruation and Menopause
por: Ornello, Raffaele, et al.
Publicado: (2021)

Fremanezumab: a disease-specific option for the preventive treatment of migraine, including difficult-to-treat migraine
por: Friedman, Deborah I., et al.
Publicado: (2020)

Preventing chronicity of migraine
por: Fanciullacci, M., et al.
Publicado: (2005)

A real‐world, observational study of erenumab for migraine prevention in Canadian patients
por: Becker, Werner J., et al.
Publicado: (2022)

Migraine day frequency in migraine prevention: longitudinal modelling approaches
por: Di Tanna, Gian Luca, et al.
Publicado: (2019)

Chronic migraine prevention with topiramate
por: Peres, M. F. P., et al.
Publicado: (2006)

The Role of Galcanezumab in Migraine Prevention: Existing Data and Future Directions
por: Gklinos, Panagiotis, et al.
Publicado: (2021)

Migraine Prevention with Erenumab: Focus on Patient Selection, Perspectives and Outcomes
por: De Matteis, Eleonora, et al.
Publicado: (2022)

Gepants for Acute and Preventive Migraine Treatment: A Narrative Review
por: Rissardo, Jamir Pitton, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2dei3untt5t4hakduomnmllm7n